Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Press Release Seagen Announces Preliminary Results from Phase 2 Clinical Trial of ADCETRIS (brentuximab vedotin) in Novel Combination of Agents for Patients with Advanced Stage Classical Hodgkin Lymph

FirstWordPharmaDecember 13, 2021

Tag: ADCETRIS , nivolumab , lymphoma

PharmaSources Customer Service